Cellectar Biosciences, Inc. announced the appointment of Brian M. Posner as vice president and chief financial officer, effective as of April 1, 2018. Mr. Posner is a strategic and financial executive with more than 30 years of diversified management experience in both public and private companies, ranging from start-ups to those with market capitalizations exceeding $1 billion. His expertise spans a range of functions including finance, accounting, information systems, risk management and investor relations.

Mr. Posner joins Cellectar from Alliqua BioMedical, where he was chief financial officer. Prior to Alliqua, he was chief financial officer at Ocean Power Technologies and at Power Medical Interventions. Earlier, Mr. Posner spent nine years at Pharmacopeia, where he rose from director of finance to chief financial officer before the company was acquired by Ligand Pharmaceuticals.

Before Pharmacopeia, he was chief financial officer and vice president of operations at Photosynthetic Harvest and regional chief financial officer at Omnicare. Mr. Posner began his career as an audit supervisor at Coopers & Lybrand which was subsequently merged to form PricewaterhouseCoopers. In this position, Brian M. Posner will report to Jim Caruso, President and Chief Executive Officer.